Coinfections in COVID-19

Antimicrobial resistance

There’s an intersection between secondary infections and AMR that some have been pointing out e.g. https://sciencespeaksblog.org/2020/04/06/covid-19-role-of-superinfections-in-novel-coronavirus-deaths-highlights-urgent-need-for-sustainable-development-of-new-antibiotics/ and usage is high in COVID-19 patients from demographic studies and CAP guidance in the UK is to use co-amoxiclav plus a macrolide (mostly azithromycin it seems). Any evidence of increased AMR?

3 Likes

A nice collection of AMR and COVID-19 publications from Issra Bulgasim at Liverpool School for Tropical Medicine.

2 Likes

Interesting perspective here:

1 Like

Call for stewardship to not be abandoned in AMR. Includes reiteration of the point that we don’t know what infections there are out there.

https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30232-9/fulltext?dgcid=raven_jbs_aip_email#.Xqp_B9764K4.twitter

2 Likes

Article for GARDP by Andrew Seaton on AMR stewardship in COVID-19

1 Like